Literature DB >> 25950639

Remote Stereoinduction in the Organocuprate-Mediated Allylic Alkylation of Allylic gem-Dichlorides: Highly Diastereoselective Synthesis of (Z)-Chloroalkene Dipeptide Isosteres.

Takuya Kobayakawa1, Tetsuo Narumi1,2, Hirokazu Tamamura1.   

Abstract

Highly diastereoselective synthesis of (Z)-chloroalkene dipeptide isosteres has been achieved by 1,4-asymmetric induction in the organocuprate-mediated allylic alkylation adjacent to the chiral center of allylic gem-dichlorides. The reaction proceeds with a variety of heterocuprates prepared from CuCN and various organometallic reagents. It allows rapid construction of valuable architectures of L,D-type and L,L-type (Z)-chloroalkene dipeptide isosteres from the corresponding (E)- and (Z)-allylic gem-dichlorides in high yields, with excellent (Z)-selectivity and diastereoselectivity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25950639     DOI: 10.1021/acs.orglett.5b00611

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  3 in total

1.  Synthesis of a Chloroalkene Dipeptide Isostere-Containing Peptidomimetic and Its Biological Application.

Authors:  Takuya Kobayakawa; Yudai Matsuzaki; Kentaro Hozumi; Wataru Nomura; Motoyoshi Nomizu; Hirokazu Tamamura
Journal:  ACS Med Chem Lett       Date:  2017-12-27       Impact factor: 4.345

2.  Stereoselective synthesis of Gly-Gly-type (E)-methylalkene and (Z)-chloroalkene dipeptide isosteres and their application to 14-mer RGG peptidomimetics.

Authors:  Hikari Okita; Yuna Kato; Tatsuki Masuzawa; Kosuke Arai; Sayuri Takeo; Kohei Sato; Nobuyuki Mase; Takanori Oyoshi; Tetsuo Narumi
Journal:  RSC Adv       Date:  2020-08-10       Impact factor: 3.361

3.  Diastereoconvergent synthesis of anti-1,2-amino alcohols with N-containing quaternary stereocenters via selenium-catalyzed intermolecular C-H amination.

Authors:  Tianyi Zheng; Janna L Berman; Forrest E Michael
Journal:  Chem Sci       Date:  2022-08-03       Impact factor: 9.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.